A recent study reveals that people who come off popular GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass much more quickly than those who halt conventional diet and exercise plans.
Published data in a prominent health publication demonstrates that while obese individuals can lose substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals purchasing such drugs must be cognizant of the potential of quick rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
That rate of recovery means a reversion to original weight in about a year and a half.
Weighing Treatments
The analysis, which looked at 37 of trials involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
Researchers note that people who lose weight through diet and exercise generally experience a more gradual weight regain—around 100 grams monthly—once they finish.
The Reason for the Fast Regain
Experts suggest the mechanism of the drugs explains the amplified regain.
The injections imitate a body's own chemical called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous GLP-1, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication results in appetite is unsuppressed, making binge eating much more probable."
A Lifelong Condition?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, considering the high risk of weight regain, the therapy should be considered ongoing.
This opinion is echoed by drug manufacturers, who note that the findings "underscore the persistent nature of excess weight," akin to managing conditions like diabetes.
User Experiences
Individuals who have discontinued the medication report a sudden resurgence of cravings.
"I experienced a trigger that goes on and you become extremely hungry," recalled a patient.
The struggle is compounded if users have not established permanent dietary or behavioural modifications during therapy.
Growing Interest
Survey data indicate that a significant number of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Adoption is greater among women than males.
- The 40s and 50s age group shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts stress that while these medications are effective agents for shedding pounds, they are not a magic fix and maintained weight loss hinges on integrated lifestyle changes.
